Use of EMPAgliflozin in the prevention of CARDiotoxicity: the EMPACARD – PILOT trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Use of EMPAgliflozin in the prevention of CARDiotoxicity: the EMPACARD – PILOT trial ; volume:10 ; number:1 ; day:5 ; month:9 ; year:2024 ; pages:1-8 ; date:12.2024
Cardio-Oncology ; 10, Heft 1 (5.9.2024), 1-8, 12.2024
- Creator
-
Daniele, Andrés J.
Gregorietti, Vanesa
Costa, Diego
López – Fernández, Teresa
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40959-024-00260-y
- URN
-
urn:nbn:de:101:1-2411212124269.175871436437
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Daniele, Andrés J.
- Gregorietti, Vanesa
- Costa, Diego
- López – Fernández, Teresa
- SpringerLink (Online service)
Other Objects (12)
Cardiotoxicity—current recommendations of prevention and treatment
Statins for the Primary Prevention of Anthracycline Cardiotoxicity: A Comprehensive Review
The prevention, detection and management of cancer treatment-induced cardiotoxicity: a meta-review
The SGLT2 Inhibitor Empagliflozin Might Be a New Approach for the Prevention of Acute Kidney Injury
The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity
Cardiac dysfunction from cancer and cancer therapy: new pathways for the prevention of late cardiotoxicity
The role of neurohormonal blockers in the primary prevention of acute-, early-, and late-onset anthracycline-induced cardiotoxicity
Challenges in the implementation of cardio-oncology trials: lessons learnt from investigating statins in the prevention of anthracycline cardiotoxicity
Beta-blockers for the primary prevention of anthracycline-induced cardiotoxicity: a meta-analysis of randomized controlled trials
Cardioprotective role of royal jelly in the prevention of celecoxib-mediated cardiotoxicity in adult male albino rats
A systematic review of the cardiotoxicity of methadone
The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
Cardiotoxicity—current recommendations of prevention and treatment
Statins for the Primary Prevention of Anthracycline Cardiotoxicity: A Comprehensive Review
The prevention, detection and management of cancer treatment-induced cardiotoxicity: a meta-review
The SGLT2 Inhibitor Empagliflozin Might Be a New Approach for the Prevention of Acute Kidney Injury
The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity
Cardiac dysfunction from cancer and cancer therapy: new pathways for the prevention of late cardiotoxicity
The role of neurohormonal blockers in the primary prevention of acute-, early-, and late-onset anthracycline-induced cardiotoxicity
Challenges in the implementation of cardio-oncology trials: lessons learnt from investigating statins in the prevention of anthracycline cardiotoxicity
Beta-blockers for the primary prevention of anthracycline-induced cardiotoxicity: a meta-analysis of randomized controlled trials
Cardioprotective role of royal jelly in the prevention of celecoxib-mediated cardiotoxicity in adult male albino rats
A systematic review of the cardiotoxicity of methadone
The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
Cardiotoxicity—current recommendations of prevention and treatment
Statins for the Primary Prevention of Anthracycline Cardiotoxicity: A Comprehensive Review
The prevention, detection and management of cancer treatment-induced cardiotoxicity: a meta-review
The SGLT2 Inhibitor Empagliflozin Might Be a New Approach for the Prevention of Acute Kidney Injury
The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity
Cardiac dysfunction from cancer and cancer therapy: new pathways for the prevention of late cardiotoxicity
The role of neurohormonal blockers in the primary prevention of acute-, early-, and late-onset anthracycline-induced cardiotoxicity
Challenges in the implementation of cardio-oncology trials: lessons learnt from investigating statins in the prevention of anthracycline cardiotoxicity
Beta-blockers for the primary prevention of anthracycline-induced cardiotoxicity: a meta-analysis of randomized controlled trials
Cardioprotective role of royal jelly in the prevention of celecoxib-mediated cardiotoxicity in adult male albino rats
A systematic review of the cardiotoxicity of methadone